Clinical Trials Logo

Clinical Trial Summary

Thalassemia is an anemia or pathological state caused by compounding absently or inadequately of one or more globin chains of hemoglobin due to the defects of the globin gene,and the carrying rate is high in southern China. Although there are many studies of Thalassemia, the relationship between the globin gene defects and the early embryo development has not been reported. This study intends to carry out a retrospective analysis on the embryonic development of the patients with thalassemia assisted by PGD from January 1, 2011 to now in our hospital, to explore whether the HBA or HBB gene defects have a certain influence on the early embryo development, so as to accumulate certain data for reproductive health research.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03687567
Study type Observational
Source Reproductive & Genetic Hospital of CITIC-Xiangya
Contact
Status Completed
Phase
Start date September 1, 2013
Completion date December 31, 2020